Glucagon‐like peptide‐1 (GLP‐1) receptor agonists in type 2 diabetes and long‐term complications: FOCUS on retinopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists in type 2 diabetes and long‐term complications: FOCUS on retinopathy

Published:2020-09-27 Issue:1 Volume:38 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Marchand L.¹^ORCID,Luyton C.¹,Bernard A.²³

Affiliation:

1. Department of Endocrinology and Diabetes Centre Hospitalier Saint Joseph Saint Luc Lyon

2. Department of Ophthalmology Hospices Civils de LyonCentre Hospitalier Lyon‐Sud Pierre‐Bénite

3. Department of Ophthalmology Centre Hospitalier Saint Joseph Saint Luc Lyon France

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14390

Reference11 articles.

1. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

2. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

4. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

5. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescription of glucagon-like peptide 1 agonists and risk of subsequent open-angle glaucoma in individuals with type 2 diabetes mellitus;International Journal of Medical Sciences;2024

2. Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes;Diabetes, Obesity and Metabolism;2023-02-21

3. Predictive model for diabetic retinopathy under limited medical resources: A multicenter diagnostic study;Frontiers in Endocrinology;2023-01-05

4. Glucagon-like peptide 1-receptor agonists and A1c: Good for the heart but less so for the eyes?;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-01

5. Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular disease;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3